1744.8000 -22.40 (-1.27%)
NSE May 09, 2025 15:31 PM
Volume: 1.1M
 

1744.80
-1.27%
Sun Pharma may incur revenue loss for ransomware incident on March 2
Business Standard
Sun Pharma Advanced Research Company may incur expenses in connection with incident; India was the second most attacked country for ransomware in the APAC-Japan region in 2022
More from Sun Pharmaceutical Industries Ltd.
Recommended